Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript

Core Insights - Agenus is focused on providing treatment options for cancer patients globally, emphasizing their commitment to oncology and immuno-oncology research [1] Group 1: Leadership and Expertise - The webcast features prominent figures in oncology, including Dr. Michael Gordon and Professor Alexander Eggermont, who will share insights on Agenus's immunotherapy combination, BOT/BAL [2][3] - Dr. Gordon will present pan-tumor data on the efficacy of BOT/BAL in treating refractory solid tumors, which was recently showcased at a major oncology congress [2] - Professor Eggermont will discuss the implications of BOT/BAL's inclusion in the French AAC program for colorectal cancer patients [3] Group 2: Engagement and Communication - Agenus leadership, including Dr. Steven O'Day, Dr. Richard Goldberg, and Robin Taylor, will participate in a live Q&A session to engage with stakeholders [3] - The company encourages audience interaction by inviting questions via email during the webcast [3]